At Pliant Therapeutics, we recognize that our success depends on the excellence of our people. With this in mind, we are highly vested in the recruitment, training and development of our employees.
We are looking for exceptional candidates who are dedicated to our corporate values and are interested in being a part of a team that is committed to developing a pipeline of innovative therapeutics to treat major unmet medical needs.
By harnessing the therapeutic potential of integrin biology and TGF-β modulation, Pliant aims to prevent or even reverse fibrosis to address the needs of many patients. The company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery.
Pliant’s co-founders include world-renowned researchers from University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.

Redwood City, US
Size (employees)
31 (est)+7%
Pliant Therapeutics was founded in 2016 and is headquartered in Redwood City, US
Report incorrect company information

Pliant Therapeutics Office Locations

Pliant Therapeutics has an office in Redwood City
Redwood City, US (HQ)
150 700 Saginaw Dr
Show all (1)
Report incorrect company information

Pliant Therapeutics Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$45 m

Latest funding size

$45 m

Time since last funding

2 years ago


Pliant Therapeutics's latest funding round in February 2016 was reported to be $45 m. In total, Pliant Therapeutics has raised $45 m
Report incorrect company information